PMID- 15127883 OWN - NLM STAT- MEDLINE DCOM- 20040625 LR - 20191026 IS - 0916-9636 (Print) IS - 0916-9636 (Linking) VI - 27 IP - 4 DP - 2004 Apr TI - Erectile dysfunction in hypertensive rats results from impairment of the relaxation evoked by neurogenic carbon monoxide and nitric oxide. PG - 253-61 AB - Erectile dysfunction (ED) with aging and diabetes mellitus is caused by impairment of the relaxation evoked by nitric oxide (NO) of penile cavernous smooth muscles and arterioles. However, the mechanism of ED in hypertension is unknown. Carbon monoxide (CO), which is produced by heme oxygenase (HO)-2 in the neuronal system is a neurotransmitter and a vasodilator. We examined the neurogenic role of CO in penile erection and the neurogenic mechanisms of ED in hypertension, using spontaneously hypertensive rats (SHR) or Wistar-Kyoto rats (WKY). The isometric tension of corpus cavernosum tissues from both strains was recorded after guanethidine and atropine treatment. Relaxation in response to electrical field stimulation (EFS) in WKY was suppressed dose-dependently by HO inhibitors both in the absence and presence of an NO synthase (NOS) inhibitor. Reverse transcription-polymerase chain reaction (RT-PCR) showed that the HO-2 gene was expressed in the corpus cavernosum. CO-saturated solution induced a concentration-dependent relaxation in WKY. The neurogenic relaxation to EFS in SHR was impaired as compared with that in WKY after the age of 5 weeks, when blood pressure began to be elevated, due to the attenuated relaxation in response to neurogenic NO and CO. In the corpus cavernosum of SHR, expression of the HO-2 and nNOS genes was similar, and NOx levels after EFS were similar to those of WKY. cGMP levels after EFS and the relaxation evoked by the NO donor was lower in SHR than WKY. Thiobarbituric acid-reacting substance (TBARS) levels were increased, and superoxide dismutase (SOD) activity was suppressed in SHR, as compared with those in WKY, suggesting that the increasing oxidative stress partially causes the impairment of NO-dependent relaxation. These findings suggest that CO regulates the relaxation evoked by EFS in the rat corpus cavernosum, and that ED in hypertension in rats results from an impairment of the relaxation induced by neurogenic CO and NO. FAU - Ushiyama, Masayuki AU - Ushiyama M AD - Fourth Department of Internal Medicine, Saitama Medical School, Saitama, Japan. FAU - Morita, Toshisuke AU - Morita T FAU - Kuramochi, Tomoya AU - Kuramochi T FAU - Yagi, Shinji AU - Yagi S FAU - Katayama, Shigehiro AU - Katayama S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Hypertens Res JT - Hypertension research : official journal of the Japanese Society of Hypertension JID - 9307690 RN - 0 (Enzyme Inhibitors) RN - 0 (Protoporphyrins) RN - 15442-64-5 (zinc protoporphyrin) RN - 31C4KY9ESH (Nitric Oxide) RN - 7U1EE4V452 (Carbon Monoxide) RN - EC 1.14.13.39 (Nitric Oxide Synthase) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type I) RN - EC 1.14.13.39 (Nos1 protein, rat) RN - EC 1.14.14.18 (Heme Oxygenase (Decyclizing)) RN - EC 1.14.14.18 (heme oxygenase-2) RN - H2D2X058MU (Cyclic GMP) SB - IM MH - Animals MH - Carbon Monoxide/*metabolism MH - Cyclic GMP/metabolism MH - Enzyme Inhibitors/pharmacology MH - Erectile Dysfunction/*etiology/*metabolism/physiopathology MH - Gene Expression Regulation, Enzymologic MH - Heme Oxygenase (Decyclizing)/antagonists & inhibitors/genetics MH - Hypertension/*complications/*metabolism/physiopathology MH - Male MH - Neurons/metabolism MH - Nitric Oxide/*metabolism MH - Nitric Oxide Synthase/genetics MH - Nitric Oxide Synthase Type I MH - Oxidative Stress MH - Penile Erection/drug effects/physiology MH - Penis/blood supply/innervation/physiopathology MH - Protoporphyrins/pharmacology MH - Rats MH - Rats, Inbred SHR MH - Rats, Inbred WKY MH - Vasodilation EDAT- 2004/05/07 05:00 MHDA- 2004/06/26 05:00 CRDT- 2004/05/07 05:00 PHST- 2004/05/07 05:00 [pubmed] PHST- 2004/06/26 05:00 [medline] PHST- 2004/05/07 05:00 [entrez] AID - 10.1291/hypres.27.253 [doi] PST - ppublish SO - Hypertens Res. 2004 Apr;27(4):253-61. doi: 10.1291/hypres.27.253.